Biomarker and Drug Discovery for Gastroenterology Through Translational Bioinformatics
To access this article, please choose from the options below
Conflicts of interest The authors disclose the following: AJB is or has served as a scientific advisor and/or consultant to NuMedii, Genstruct, Prevendia, Tercica, Eli Lilly and Company, and Johnson and Johnson. JTD has served as a consultant to NuMedii.
Funding Grant support from the National Library of Medicine (T15 LM007033 and R01 LM009719).
PII: S0016-5085(10)01076-0
doi:10.1053/j.gastro.2010.07.024
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

